322 related articles for article (PubMed ID: 24406219)
1. Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter.
Yan C; Yang M; Li Z; Li S; Hu X; Fan D; Zhang Y; Wang J; Xiong D
Biomaterials; 2014 Mar; 35(9):3035-43. PubMed ID: 24406219
[TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma.
Yan C; Li S; Li Z; Peng H; Yuan X; Jiang L; Zhang Y; Fan D; Hu X; Yang M; Xiong D
Mol Pharm; 2013 Jan; 10(1):142-51. PubMed ID: 23121392
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically.
Yuan X; Zhang Q; Li Z; Zhang X; Bao S; Fan D; Ru Y; Dong S; Zhang Y; Zhang Y; Ye Z; Xiong D
Cancer Lett; 2016 Oct; 381(1):85-95. PubMed ID: 27450327
[TBL] [Abstract][Full Text] [Related]
4. E1A-engineered human umbilical cord mesenchymal stem cells as carriers and amplifiers for adenovirus suppress hepatocarcinoma in mice.
Li Z; Ye Z; Zhang X; Zhang Q; Fan D; Zhang Y; Luo HR; Yuan X; Li Z; Xiong D
Oncotarget; 2016 Aug; 7(32):51815-51828. PubMed ID: 27322080
[TBL] [Abstract][Full Text] [Related]
5. Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.
Yan C; Song X; Yu W; Wei F; Li H; Lv M; Zhang X; Ren X
Tumour Biol; 2016 Jun; 37(6):8425-35. PubMed ID: 26733169
[TBL] [Abstract][Full Text] [Related]
6. Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells.
Zhang Q; Yuan XF; Lu Y; Li ZZ; Bao SQ; Zhang XL; Yang YY; Fan DM; Zhang YZ; Wu CX; Guo HX; Zhang YJ; Ye Z; Xiong DS
Int J Cancer; 2017 Oct; 141(7):1445-1457. PubMed ID: 28643325
[TBL] [Abstract][Full Text] [Related]
7. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
[TBL] [Abstract][Full Text] [Related]
8. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma].
Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL
Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267
[TBL] [Abstract][Full Text] [Related]
9. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
10. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
[TBL] [Abstract][Full Text] [Related]
11. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
[TBL] [Abstract][Full Text] [Related]
12. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord and dental pulp-derived mesenchymal stem cells: biological characteristics and potential roles in vitro and in vivo.
Cui X; Chen L; Xue T; Yu J; Liu J; Ji Y; Cheng L
Mol Med Rep; 2015 May; 11(5):3269-78. PubMed ID: 25591506
[TBL] [Abstract][Full Text] [Related]
14. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.
Abd-Allah SH; Shalaby SM; El-Shal AS; Elkader EA; Hussein S; Emam E; Mazen NF; El Kateb M; Atfy M
Cytotherapy; 2014 Sep; 16(9):1197-206. PubMed ID: 24985939
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with human umbilical cord mesenchymal stem cells and angiotensin-converting enzyme 2 is superior for the treatment of acute lung ischemia-reperfusion injury in rats.
Zhang X; Gao F; Yan Y; Ruan Z; Liu Z
Cell Biochem Funct; 2015 Apr; 33(3):113-20. PubMed ID: 25756848
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of alpha-fetoprotein promoter-mediated tBid and chemotherapeutic agents on orthotopic liver tumor in mice.
Ma SH; Chen GG; Yip J; Lai PB
Gene Ther; 2010 Jul; 17(7):905-12. PubMed ID: 20336154
[TBL] [Abstract][Full Text] [Related]
17. Programming of human umbilical cord mesenchymal stem cells in vitro to promote pancreatic gene expression.
Wang H; Yang Y; Ho G; Lin X; Wu W; Li W; Lin L; Feng X; Huo X; Jiang J; Liu X; Huang T; Wei C; Ma L
Mol Med Rep; 2013 Sep; 8(3):769-74. PubMed ID: 23900717
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
19. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter.
Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J
Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis.
Tsai PC; Fu TW; Chen YM; Ko TL; Chen TH; Shih YH; Hung SC; Fu YS
Liver Transpl; 2009 May; 15(5):484-95. PubMed ID: 19399744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
